These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7437240)

  • 1. Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.
    Martin MA; Bax ND; Tucker GT; Ward JW
    Br J Clin Pharmacol; 1980 Sep; 10(3):237-44. PubMed ID: 7437240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.
    Pollick C; Giacomini KM; Blaschke TF; Nelson WL; Turner-Tamiyasu K; Briskin V; Popp RL
    Circulation; 1982 Aug; 66(2):447-53. PubMed ID: 7094252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac effects of disopyramide and lignocaine assessed by echocardiography [proceedings].
    Bax ND; Martin MA; Tucker GT; Ward JW
    Br J Clin Pharmacol; 1979 Oct; 8(4):398P-399P. PubMed ID: 508536
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.
    Walsh RA; Horwitz LD
    Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effects of disopyramide and lidocaine on negative inotropic action--evaluation by multigated RI angiography (author's transl)].
    Kito Y; Fujita T; Kosakai Y; Naito Y; Koyanagi H; Ohara K; Ego Y; Hayashi K; Manabe H; Nishimura T; Kozuka T
    Kokyu To Junkan; 1981 Apr; 29(4):405-10. PubMed ID: 7255990
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 14. Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.
    Grant AM; Marshall RJ; Ankier SI
    Eur J Pharmacol; 1978 Jun; 49(4):389-94. PubMed ID: 668810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1979 Jun; 66(2):241-50. PubMed ID: 465877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.